International textbooks on infectious diseases and antibacterial chemotherapy are usually written for readers in North America and Europe. In many ways, they are not appropriate for the prob lems encountered in developing countries. This book, in contrast, intends to define the rules of antibacterial chemotherapy practised under conditions of limited resources. It is meant for everyone con cerned with the use of antibiotics in developing countries, includ ing doctors, medical assistants, pharmacists, officials in health mio isteries, and medical students. Throughout the book, treatment recommendations are made for 1 antibiotics from the WHO list of essential drugs. For example, em phasis has therefore been put upon chloramphenicol as a stable, unexpensive and widely available oral agent suitable for the treat ment of severe bacterial infections like septicemia and meningitis. So-called "international chemotherapy" with modem cephalospor ins and acylaminopenicillins has been outlined for comparison. Since it is the aim of the book to base treatment recommenda tions on data from developing countries, many data on the etiology of common bacterial infections in developing countries have also been included. Most of the data are from African, English-speak ing developing countries, but references have been made to the lit erature on South East Asia, India or Papua New Guinea, where appropriate. On the other hand, pertinent data were not available in every instance, so that several statements and recommendations had to be made as "best guess". The authors are aware of these imperfections and will welcome comments from the readers.
Sabine Stübler compares different proteasome isoforms and subtypes in terms of their transport and active site-related parameters applying an existing computational model. In a second step, the author extends this model to be able to describe the influence of proteasome inhibitors in in vitro experiments. The computational model, which describes the hydrolysis of short fluorogenic peptides by the 20S proteasome, is calibrated to experimental data from different proteasome isoforms using an approximate Bayesian computation approach. The dynamics of proteasome inhibitors are included into the model in order to demonstrate how to modulate the inhibitor’s transport parameters for strong or isoform-specific inhibition.
International textbooks on infectious diseases and antibacterial chemotherapy are usually written for readers in North America and Europe. In many ways, they are not appropriate for the prob lems encountered in developing countries. This book, in contrast, intends to define the rules of antibacterial chemotherapy practised under conditions of limited resources. It is meant for everyone con cerned with the use of antibiotics in developing countries, includ ing doctors, medical assistants, pharmacists, officials in health mio isteries, and medical students. Throughout the book, treatment recommendations are made for 1 antibiotics from the WHO list of essential drugs. For example, em phasis has therefore been put upon chloramphenicol as a stable, unexpensive and widely available oral agent suitable for the treat ment of severe bacterial infections like septicemia and meningitis. So-called "international chemotherapy" with modem cephalospor ins and acylaminopenicillins has been outlined for comparison. Since it is the aim of the book to base treatment recommenda tions on data from developing countries, many data on the etiology of common bacterial infections in developing countries have also been included. Most of the data are from African, English-speak ing developing countries, but references have been made to the lit erature on South East Asia, India or Papua New Guinea, where appropriate. On the other hand, pertinent data were not available in every instance, so that several statements and recommendations had to be made as "best guess". The authors are aware of these imperfections and will welcome comments from the readers.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.